Evidence map›Paper›PMID 38187596›Full record

ArticlebioRxiv : the preprint server for biology2025

Heterogeneity-Preserving Discriminative Feature Selection for Disease-Specific Subtype Discovery.

Abdur Rahman M A Basher, Caleb Hallinan, Kwonmoo Lee

Open access · greenAbstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Abdur Rahman M A BasherVascular Biology Program, Boston Children's Hospital, Boston, MA 02115, USA.
Caleb HallinanVascular Biology Program, Boston Children's Hospital, Boston, MA 02115, USA.
Kwonmoo LeeVascular Biology Program, Boston Children's Hospital, Boston, MA 02115, USA.ORCID 0000-0001-6838-7094
Boston Children's Hospital · US

Funding

Unraveling subcellular heterogeneity of molecular coordination by machine learningR35GM133725 · NIGMS · WORCESTER POLYTECHNIC INSTITUTE · PI Kwonmoo Lee · 2019 to 2026
$3.9M
High-throughput Phenotyping of iPSC-derived Airway Epithelium by Multiscale Machine Learning MicroscopyR01HL163513 · NHLBI · BOSTON CHILDREN'S HOSPITAL · PI Hakho Lee, Kwonmoo Lee · 2023 to 2026
$3.1M
NHLBI NIH HHS R01 HL163513NIGMS NIH HHS R35 GM133725
6 · The paper itself

Abstract

The identification of disease-specific subtypes can provide valuable insights into disease progression and potential individualized therapies, important aspects of precision medicine given the complex nature of disease heterogeneity. The advent of high-throughput technologies has enabled the generation and analysis of various molecular data types, such as single-cell RNA-seq, proteomic, and imaging datasets, on a large scale. While these datasets offer opportunities for subtype discovery, they also pose challenges in finding subtype signatures due to their high dimensionality. Feature selection, a key step in the machine learning pipeline, involves selecting signatures that reduce feature size for more efficient downstream computational analysis. Although many existing methods focus on selecting features that differentiate known diseases or cell states, they often struggle to identify features that both preserve heterogeneity and reveal subtypes. To address this, we utilized deep metric learning-based feature embedding to explore the statistical properties of features crucial for preserving heterogeneity. Our analysis indicated that features with a notable difference in interquartile range (IQR) between classes hold important subtype information. Guided by this insight, we developed a statistical method called PHet (Preserving Heterogeneity), which employs iterative subsampling and differential analysis of IQR combined with Fisher's method to identify a small set of features that preserve heterogeneity and enhance subtype clustering quality. Validation on public single-cell RNA-seq and microarray datasets demonstrated PHet's ability to maintain sample heterogeneity while distinguishing known disease/cell states, with a tendency to outperform previous differential expression and outlier-based methods. Furthermore, an analysis of a single-cell RNA-seq dataset from mouse tracheal epithelial cells identified two distinct basal cell subtypes differentiating towards a luminal secretory phenotype using PHet-based features, demonstrating promising results in a real-data application. These results highlight PHet's potential to enhance our understanding of disease mechanisms and cell differentiation, contributing significantly to the field of personalized medicine.

Identifiers

PMID38187596
PMCPMC10769187
OpenAlexW4376617873

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.